Annual EBITDA
-$6.49 M
-$27.46 M-130.97%
31 December 2023
Summary:
InterCure annual earnings before interest, taxes, depreciation & amortization is currently -$6.49 million, with the most recent change of -$27.46 million (-130.97%) on 31 December 2023. During the last 3 years, it has risen by +$3.56 million (+35.38%). INCR annual EBITDA is now -130.97% below its all-time high of $20.97 million, reached on 31 December 2022.INCR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
N/A
01 June 2024
Summary:
InterCure quarterly earnings before interest, taxes, depreciation & amortization is not available.INCR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
N/A
01 June 2024
Summary:
InterCure TTM earnings before interest, taxes, depreciation & amortization is not available.INCR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INCR EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -131.0% | - | - |
| 3 y3 years | +35.4% | - | - |
| 5 y5 years | -98.3% | - | - |
INCR EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -131.0% | +35.4% | ||||
| 5 y | 5 years | -131.0% | +35.4% | ||||
| alltime | all time | -131.0% | +35.4% |
InterCure EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$6.49 M(-131.0%) | - | - |
| June 2023 | - | $1.79 M(-40.7%) | $9.58 M(-37.3%) |
| Mar 2023 | - | $3.02 M(-5927.0%) | $15.28 M(-22.8%) |
| Dec 2022 | $20.97 M(+117.2%) | -$51.90 K(-101.1%) | $19.79 M(-11.4%) |
| Sept 2022 | - | $4.82 M(-35.7%) | $22.33 M(+14.9%) |
| June 2022 | - | $7.49 M(-0.5%) | $19.44 M(+30.3%) |
| Mar 2022 | - | $7.53 M(+202.3%) | $14.91 M(+56.8%) |
| Dec 2021 | $9.65 M(-196.0%) | $2.49 M(+29.3%) | $9.51 M(-389.7%) |
| Sept 2021 | - | $1.93 M(-35.1%) | -$3.28 M(-13.7%) |
| June 2021 | - | $2.97 M(+39.3%) | -$3.80 M(-44.9%) |
| Mar 2021 | - | $2.13 M(-120.7%) | -$6.91 M(-33.1%) |
| Dec 2020 | -$10.05 M(+850.4%) | -$10.31 M(-833.1%) | -$10.33 M(+108.1%) |
| Sept 2020 | - | $1.41 M(-1129.2%) | -$4.96 M(-52.1%) |
| June 2020 | - | -$136.60 K(-89.4%) | -$10.37 M(-20.7%) |
| Mar 2020 | - | -$1.29 M(-73.8%) | -$13.07 M(+849.7%) |
| Dec 2019 | -$1.06 M(-67.7%) | - | - |
| Dec 2019 | - | -$4.94 M(+23.5%) | -$1.38 M(-138.6%) |
| Sept 2019 | - | -$4.00 M(+40.8%) | $3.56 M(-52.9%) |
| June 2019 | - | -$2.84 M(-127.3%) | $7.56 M(-27.3%) |
| Mar 2019 | - | $10.40 M(-7018.6%) | $10.40 M(+6431.8%) |
| Dec 2018 | -$3.28 M(+142.5%) | - | - |
| Dec 2017 | -$1.35 M(-906.7%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $167.50 K(-134.6%) | -$150.30 K(-235.8%) | $159.20 K(+552.5%) |
| Sept 2016 | - | $110.70 K(-171.0%) | $24.40 K(-108.8%) |
| June 2016 | - | -$155.90 K(-144.0%) | -$278.80 K(+340.4%) |
| Mar 2016 | - | $354.70 K(-224.4%) | -$63.30 K(-84.2%) |
| Dec 2015 | -$484.10 K(-54.2%) | -$285.10 K(+48.1%) | -$399.90 K(+34.0%) |
| Sept 2015 | - | -$192.50 K(-423.0%) | -$298.50 K(-41.5%) |
| June 2015 | - | $59.60 K(+229.3%) | -$510.10 K(-30.8%) |
| Mar 2015 | - | $18.10 K(-109.9%) | -$737.40 K(-17.4%) |
| Dec 2014 | -$1.06 M(-40.2%) | -$183.70 K(-54.5%) | -$893.00 K(-21.1%) |
| Sept 2014 | - | -$404.10 K(+141.0%) | -$1.13 M(-15.7%) |
| June 2014 | - | -$167.70 K(+22.0%) | -$1.34 M(-15.1%) |
| Mar 2014 | - | -$137.50 K(-67.5%) | -$1.58 M(-10.0%) |
| Dec 2013 | -$1.77 M(-115.0%) | -$422.90 K(-31.3%) | -$1.76 M(-50.7%) |
| Sept 2013 | - | -$615.70 K(+51.7%) | -$3.57 M(-135.4%) |
| June 2013 | - | -$405.80 K(+29.3%) | $10.08 M(-9.3%) |
| Mar 2013 | - | -$313.90 K(-85.9%) | $11.12 M(-2.1%) |
| Dec 2012 | $11.80 M(+7631.7%) | -$2.23 M(-117.1%) | $11.36 M(-16.4%) |
| Sept 2012 | - | $13.03 M(+1978.5%) | $13.59 M(+2352.3%) |
| June 2012 | - | $627.10 K(-959.0%) | $554.10 K(-859.0%) |
| Mar 2012 | - | -$73.00 K | -$73.00 K |
| Dec 2011 | $152.60 K(-117.7%) | - | - |
| Dec 2010 | -$860.20 K | - | - |
FAQ
- What is InterCure annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for InterCure?
- What is InterCure annual EBITDA year-on-year change?
- What is the all time high quarterly EBITDA for InterCure?
- What is the all time high TTM EBITDA for InterCure?
What is InterCure annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of INCR is -$6.49 M
What is the all time high annual EBITDA for InterCure?
InterCure all-time high annual earnings before interest, taxes, depreciation & amortization is $20.97 M
What is InterCure annual EBITDA year-on-year change?
Over the past year, INCR annual earnings before interest, taxes, depreciation & amortization has changed by -$27.46 M (-130.97%)
What is the all time high quarterly EBITDA for InterCure?
InterCure all-time high quarterly earnings before interest, taxes, depreciation & amortization is $13.03 M
What is the all time high TTM EBITDA for InterCure?
InterCure all-time high TTM earnings before interest, taxes, depreciation & amortization is $22.33 M